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had to do with a poisoning case caused by C. Botulinum
by food. The case was treated with botulinum anatoxin
type B.
Conclusion: This case shows that there are still rare diseases
that may occur and which might be without speciﬁc clinical
and biochemical signs, without anamnesis data, so we
should be attentive to diagnose these cases and reanimate
in order to minimize death cases.
PP-041 Efﬁcacy of chloramphenicol combinatied with
erythromycin in treatment of 21 pneumonia
patients infected with multi-drug resistant
Pseudomonas aeruginosa
S. Jin1 *, W.-G. Liu2. 1Second Afﬁliated Hospital of
Chongqing Medical University, 2Second Neijiang City
Hospital of Sichuan Province, China
Background: Following antibiotics being used in hospitals
generally, pneumonia patients infected with multi-drug
resistant P. aeruginosa can not be ignored. The aim of this
research was to observe the efﬁcacy of chloramphenicol
combined with erythromycin in treatment of pneumonia
infected with multi-drug resistant P. aeruginosa.
Methods: A retrospective clinical study on 21 patients with
pneumonia infected with multi-drug resistant P. aeruginosa
was carried out from January 2007 to December 2010.
Clinical features, drug-resistant features and results of
susceptibility test were analysed.
Result: All of the 21 patients were resistant to the third
generation cephalosporin and carbostyril. Treated with
imipenem and sodium cilastatin, mesomerism observed
in 16 patients, and drug resistance appeared in ﬁve
patients. Then, switched to treating with chloramphenicol
combined with erythromycin, 12 patients cured, ﬁve
patients improved, inefﬁcacy appeared in four patients.
Totally, ratio of patients improved was 23.8 percent while
which of patients cured was 57.4 percent. 80.94 percent of
all the drug-resistant patients were improved.
Conclusion: Incidence rate of pneumonia associated with
P. aeruginosa is always higher than that resulting from
other etiological agents. Diagnosed in time and treated with
suitable antibiotic are proﬁted to cure and prevention of
hospital acquired pneumonia resulting from P. aeruginosa.
PP-042 A case with erysipelas caused by beta hemolytic
Streptococcus, as a cause of sepsis state
J. Nadire1 *. 1Regional hospital, department of infections
diseases, Albania
Erysipelas is an acute infection, used by Group A
beta hemolytic Streptococcus. It is characterized by
inﬂammatory plaque well limited by surrounded tissues that
affect the face and the trunk.
In order to develop erysipelas it must be a focus with
small invisible ﬁssures under the skin, from streptococcal
infection of the wounds, chirurgical incision or in areas with
dermatophytosis.
To develop streptococcal septicemia it must be a septic
focus in the organism, from which microbes occasionally
jump in circulation.
Streptococcal infections may assume the character of
septicemia at the presence of favorable conditions such as
the lower of organism’s resistance because of malnutrition,
fatigue, serious diseases convalescence.
Presentation case: Patient N.B, 70 years, appeared at the
infective disease clinic with the diagnose: Erysipelas cruris
sin.
The patient presented: temp 40 degrees, PA 70/40mm Hg,
tachycardia 90′, accentuated redness and edema of the left
crural region.
The main examinations were taken and the treatment
started with Tazocina 4.5×4 ﬂ i.v, amikacin 500mg×2 i.v,
solution, NaHCO3, K and vasoconstrictor like dopamine.
Examinations: Erythrocytes 3,700,000, Leukocytes 13,000,
Azotemia 180mg%, Creatinine 4.3mg%, Glucose 87mg%,
the patient had anuria in spite of the presence of the
catheter. From the microbiological examination it resulted
Beta hemolytic Streptococal. Patient has acrocyanosis signs
at the toes, cellulite, predisposed by hypotension and CID.
Discussion: Streptococcal infections may assume the
character of septicemia at the presence of favorable
conditions such as the lower of organism’s resistance.
Conclusions: Streptococcal diseases remain one of the most
problematic morbidity for the organism. The importance
of the problem solution is: early diagnosis, adequate
and efﬁcient treatment, preventing systemic multi-organ
complications.
PP-043 Staphylococcus epidermidis contains ampicillin
resistant gene
B.G. Arshad1 *, W. Shehzad1, S.A. Malik1, S. Shakeel1,
A. Raza2. 1Department of Biochemistry, Quaid-i-Azam
University, Islamabad, 2Nuclear Medicines Oncology and
Radiotherapy Institute, Islamabad, Pakistan
Background and Objective: Staphylococcus epidermidis is
coagulase negative, gram positive cocci that reside naturally
on human skin. Staphylococcus epidermidis has emerged as
a major nosocomial pathogen. The main objective of the
study was to determine whether Staphylococcus epidermidis
contains any antibiotic resistance gene. Also to ascertain
the size of the plasmid of clinical isolates of Staphylococcus
epidermidis collected locally and to ﬁnd out the restriction
sites present in the plasmid.
Methods: Conventional Strains of Staphylococcus epider-
midis were collected from Pakistan Institute of Medical
Sceinces (PIMS), Islamabad, Pakistan and identiﬁed by
using different biochemical tests. Overnight shaking of
Staphylococcus epidermidis colonies at 250 rpm at 37ºC was
done, in LB medium containing Ampicillin. Alkaline miniprep
extraction protocol and Gene JETTM Plasmid Miniprep kit
(Fermentas) protocol were used to isolate plasmid DNA.
The isolated plasmid was checked for restriction fragment
by using EcoRI and Hind III restriction endonucleases.
Results: The clinically isolated samples of Staphylococcus
epidermidis were negative for Indole production test and
Citrate utilization test. Samples were positive for Nitrate
reduction test, Starch hydrolysis test and Catalase test.
After overnight shaking at 250 rpm at 37ºC bacterial growth
appeared in the LB medium containing Ampicillin. Alkaline
miniprep extraction gave minimum yield for Staphylococcus
epidermidis. Gene JETTM Plasmid Miniprep kit (Fermentas)
gave higher yields and comparatively pure DNA. It was found
that Staphylococcus epidermidis had plasmid of size 14kb.
Restriction fragments of 10kb and 4kb were obtained when
plasmid was digested with EcoRI. The plasmid remained
intact when digested with Hind III. The resulted fragments
were analysed on 1% agarose gel.
Conclusion: Clinical isolates of Staphylococcus epidermidis
contains Ampicillin Resistant Gene.
PP-044 Analysis of 87 septicemia cases
H.Y. Chen1, Y. Wang1, M.S. Jin1, F. Wang1 *. 1First hospital
of Jilin University, China
Background: Septicemia are commom in the infectious
disease department or the emergency departments.
Pathogens and primary infection maybe different among
different departments. The objective of this study was to
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examine the epidemiology and microbiology of bacteremia
in adult patients who hospitalized in the infectious disease
department of First Hospital, Jilin University.
Methods: A retrospective observational study involving 87
adult septicemia patients and 113 blood cultures (Oct
2010-Apr 2011) of septicemia cases was performed in the
infectious disease department, and the epidemiology and
microbiology were analysised.
Results: Among these blood cultures, 38 (33.6%) were
pathogens positive. Most common pathogen was Escherichia
coli 11 (40.7%), then Staphylococcus 5 (18.5%). Urinary
tract infections (41.4%, 36/87) were most common in these
patients. Liver abscess (10.7%, 9/87) were risk factor of
septicemia too.
Conclusions: Gram-negative bacterias is main pathogens of
septicemia in our department. Infections such as urinary
tract infections, liver abscess, and so on, should be pay
more attention.
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PP-045 Pathophysiology of cryptosporidiosis in
immunosuppressed Balb/c and C57bl/6 mice
models
H. Nahrevanian1 *, L. Abedinzadeh2, A. Eslamifar3,
M. Amini1, S. Naeimi1. 1Department of Parasitology,
Pasteur Institute of Iran, Tehran, Iran, 2Faculty of
Sciences, Mohagheghe Ardabili University, Ardabil, Iran,
3Department of Clinical Research, Pasteur Institute Iran,
Tehran, Iran
Background: Cryptosporidiosis is caused by protozoan
parasite Cryptosporidium spp. and leads to an
acute/chronic gastroenteritis. The incidence rate of
infection in immunosuppressed patients suffering from
diarrhea was highly reported. This study was carried out
to evaluate the proliferation of the parasite from different
sources of Iranian species of Cryptosporidium spp. and to
study its pathophysiology in immunosuppressed mice.
Methods: Mice, calves and human stools samples were
collected, centrifuged by Paraseb kit, smears were
prepared and stained with acid fast assay and examined
microscopically. Oocysts were identiﬁed, separated and
concentrated by sucrose ﬂoatation. Balb/c and C57bl/6
mice were immunosuppressed by by I.P. Dexamethasone
injection; immonusuppression was conﬁrmed by lymphocyte
proliferation, and isolated oocysts from different sources
were orally inoculated into mice. The parasite replication
was assessed daily to conﬁrm proliferation of parasite.
Among the positive samples, animals were humanely killed
and the target organs (lungs, liver, intestine, spleen)
were removed, stained with Hematoxyline Eosine for
histopathological examination.
Results: The results showed more susceptibility of C57bl/6
mice rather than the Balb/c one; therefore the infection
was developed faster in C57bl/6 mice. No histopathology
was observed in H&E stained sections of target organs
and no oocysts was detected in impression smears of both
Balb/c and C57bl/6 mice. No extra-intestinal infection was
detected in study groups, which may due to short period of
infection in experimental animals.
Conclusion: These ﬁndings emphasized more susceptibility
of immunosuppressed C57bl/6 than Balb/c mice
to Cryptosporidium spp. infection. In addition, no
histopathology were detected in a short period up to
three weeks of experimental cryptosporidiosis, which may
need longer period to allow parasite for extra-intestinal
infection.
PP-046 The role of Fas mutation on nutritional
steatohepatitis in mice
Y.-M. Nan1, S.-S. Su1 *, R.Q. Wang1, F. Han1, L.-B. Kong1.
1Department of Traditional and Western Medical
Hepatology, Third Hospital of Hebei Medical University,
Shijiazhuang 050051, China
Objective: Our previous study has indicated that the Fas
pathway played a key role in hepatocyte apoptosis in
nutritional steatohepatitis in mice. This study aimed to
explore whether Fas mutation accelerated hepatic steatosis
and inﬂammatory inﬁltration in nutritional steatohepatitis
in mice.
Methods: Mice homozygous for the lymphoproliferation
spontaneous mutation (C57BL/6J-Faslpr) and wild type
C57BL/6J mice were fed a methionine-choline deﬁcient
(MCD) diet for three weeks to induce non-alcoholic
steatohepatitis (NASH). The role of Fas gene mutation on
NASH was assessed by comparing the severity of hepatic
steatosis and inﬂammation, mRNA and protein expression
of hepatic inﬂammatory and ﬁbrogenetic related factors,
proliferating cell nuclear antigen (PCNA) and transforming
growth factor-b1 (TGFb1).
Results: At weeks 3, MCD diet induced hepatic steatosis and
inﬂammatory inﬁltration in both of wild type and Faslpr mice.
Especially, severe hepatic injury was observed in Faslpr mice
compared with wild type mice, which was associated with
up-regulated cell proliferation factor PCNA and ﬁbrogenetic
growth factors TGFb1.
Conclusions: Faslpr mice developed more severe hepatic
injury including hepatic steatosis and inﬂammatory
inﬁltration induced by MCD diet compared with wild type
mice, which might associated with excessive release of cell
proliferation, inﬂammatory and ﬁbrogenetic factors.
PP-047 Effect of rosiglitazone on hepatic oxidative
stress in fructose-induced fatty liver disease
M. Grozovski1 *, M. Oron-Herman2, E. Peleg2, R. Safadi3,
Z. Ackerman3. 1Ort Braude College, Karmiel, Israel,
2Hypertension Unit, Sheba Medical Center, Tel Hashomer,
Isreal, 3Medical Center, Hadassah-Hebrew University,
Jerusalem, Israel
Aim: We characterize changes in liver pathology, hepatic
lipid composition and hepatic oxidative-anti-oxidative
milieu in rats given fructose enriched diet (FED) and the
PPAR-g agonist Rosiglitazone.
Methods: Sprague-Dawley rats, divided into 2 groups were
studied: Rats on standard chow diet and on FED for 6 weeks,
but in the last 2 weeks of the study period FED-rats received
Rosiglitazone (10mg/kg/day).
Results: FED rats had increase in the content
of hepatic triglyceride, cholesterol, malondialdehyde
(MDA), glutathione reductase (GSSG-R), but decrease in
phospholipids, a-tocopherol, paraoxonase (PON) levels. No
changes in adiponectin, TGF-b or in TNF-a plasma levels.
FED rats had macro and micro vesicular hepatic fat deposits
and an increase in relative ﬁbrosis area. Administration
of Rosiglitazone had decrease in the hepatic triglycerides,
MDA and GSSG-R levels, increase in hepatic phospholipids
content, PON activity. Rosiglitazone caused an increase in
adiponectin plasma and a decrease in the hepatic macro
vesicular, but no change in hepatic micro vesicular and
inﬂammatory score nor in the relative ﬁbrosis area.
Conclusions: Administration of Rosiglitazone to rats with
the MS, may improve hepatic lipid metabolism and the
hepatic oxidative-anti oxidative milieu.
